Vista Partners Initiates Coverage on CytoSorbents Corporation (OTCQB: CTSO); $0.50 Price Target

Vista Partners Initiates Coverage on CytoSorbents Corporation (OTCQB: CTSO); 
$0.50 Price Target 
SAN FRANCISCO, CA -- (Marketwired) -- 01/29/14 --  Vista Partners
announced today that it has initiated coverage on CytoSorbents
Corporation (OTCQB: CTSO) ("The Company," or "CTSO"); with a twelve
month price target of $0.50. Ross Silver, Principal Analyst at Vista
Partners, stated, "The Company is on the "ground floor" of
commercialization and positioned to potentially create significant
value with their approved product, CytoSorb(R), which has the
potential to revolutionize critical care medicine; save lives, and
reduce cost. CytoSorb(R) and the other products in the Company's
pipeline may have significant upside, considering the massive markets
they seek to address. The Company has received validation of their
technology from many large organizations including: Biocon, DARPA,
U.S. Army, U.S. Air Force, NIH/NHLBI, scientific advisors & analysts.
The Company enjoys a unique, high margin product and pipeline with
little to no current competition."  
To download a FREE copy of the CytoSorbents Corporation research
report, please visit and click the
"download research" icon to gain access to the report.  
About Vista Partners:
 Vista Partners LLC, founded in 2005, is a
Registered Investment Advisor in the States of California and Oregon.
The firm's professional staff has backgrounds in finance, corporate
communications and investment banking. Vista focuses on investing
globally across all market sectors. Vista also provides investment
considerations on publicly traded companies through a platform of
stock research reports, newsletters, company specific webpages and
daily commentary. The platform of products is meant to serve as
potential tools for investors to learn about investment
considerations. It is Vista's mission to provide investors with tools
that may enable them to make profitable investment decisions with the
goal to deliver investment considerations that outperform small, mid
and large cap equity indexes.  
Please follow us on Twitter @VistaPResearch & Facebook at
Vista-Partners to receive updates, thoughts and ideas about and our
coverage universe of companies and more. 
Disclaimer & Disclosure:
 For a full list of disclaimers and
disclosures, please visit our website or click
Vista Partners
Press spacebar to pause and continue. Press esc to stop.